FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results

SAN FRANCISCO, Feb. 20, 2024 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) will announce fourth quarter and full year 2023 financial results on Monday, February 26 after the market close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time with the investment community to…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks